Anhui Fengyuan Pharmaceutical Co., Ltd.

000153.SZ

000153.SZAnhui Fengyuan Pharmaceutical Co., Ltd. CN flag

Shenzhen Stock Exchange

6.16

CNY

-0.14

(-2.22%)

0.33EPS

18.67P/E

2.86BMarket Cap

May 22Next Earn

Upgrade to Unlock Non-US CompaniesTo view real-time data and analysis of companies outside of the United States, upgrade your account to our premium subscription.

Upgrade

ISIN

CNE0000014X5

Return %

Stock

S&P500

10.79

9.99

3.88

59.68

6.21

94.43

Use logarithmic scale

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	TTM
Revenue per Share	4.55	3.65	3.89	3.59	4.65	5.89	6.79	7.4	7.6	8.36	9.02	9.2	9.22	8.83
Basic EPS, GAAP	0.05	0.07	0.09	0.08	0.1	0.15	0.14	0.18	0.24	0.28	0.35	0.34	0.35	0.33
Free Cash Flow per Basic Share	-0.14	-0.44	-0.38	0.02	0.13	0.01	0.34	-0.18	0.23	0.24	0.81	0.22	-0.04	-0.44
Dividend per Share	0.06	0.12	0.07	0.07	0.14	0.08	0.07	0.12	0.09	0.06	0.13	0.14	0.16	0.16
Book Value per Share	1.21	1.17	1.21	1.25	1.28	1.44	1.55	1.67	1.9	2.19	2.47	2.63	3.13	3.21
Tangible Book Value per Share	1.63	2.24	2.2	2.32	2.29	2.45	2.51	2.62	2.81	3.52	3.38	3.5	3.75	3.84
Basic Weighted Avg Shares	364	419	437	437	437	438	444	438	437	437	444	465	465	465
Sales/Revenue/Turnover	1,658	1,530	1,699	1,569	2,034	2,578	3,013	3,238	3,321	3,652	4,004	4,275	4,285	4,105
Operating Margin (%)	2.24	3.35	3.87	4.1	4.52	5.16	4.61	4.86	4.85	5.52	5.8	5.66	5.76	5.31
Depreciation Expense	52	59	69	64	69	75	75	71	71	115	122	126	128	- -
Net Income, GAAP	19	27	41	35	46	65	61	81	104	123	154	159	161	152
Effective Tax Rate (%)	28.45	33.93	27.09	25.31	31.32	32.41	34.79	32.79	26.08	26.26	25.38	26.8	24.47	20.12
Profit Margin (%)	1.15	1.79	2.41	2.24	2.25	2.53	2.02	2.5	3.12	3.37	3.86	3.73	3.75	3.7
Working Capital	10	266	9	-26	-71	6	-52	-296	-363	-70	-267	-111	-223	-146
LT Debt	60	197	68	59	43	- -	- -	105	65	115	190	195	213	288
Total Equity	775	1,120	1,147	1,199	1,153	1,220	1,292	1,327	1,448	1,771	1,755	1,919	2,046	2,090
Return on Invested Capital (%)	2.52	2.52	2.95	2.81	3.6	5.13	5.27	5.83	5.8	6.49	6.91	6.77	6.55	5.79
Return on Capital (%)	4.5	4.62	6.13	5.36	5.77	7.68	7.41	8.89	9.38	9.95	10.36	9.67	8.49	7.69
Return on Common Equity (%)	4.41	5.89	8.05	6.55	8.31	11	9.25	11.42	13.29	13.77	15.05	13.75	12.02	11

Capital Structure

•

in mil. unless spec.

Working Capital

•

in mil. unless spec.

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)	10 years	5 years	1 year
Sales/Revenue/Turnover	10.22%	5.83%	0.21%
Net Income, GAAP	16.12%	15.29%	0.97%
Free Cash Flow	319.53%	-34.51%	-117.32%
Total Cash Common Dividend	18.85%	17.11%	12.46%
Total Equity	6.16%	9.29%	6.62%

Growth Rates

•

in mil. unless spec.

Quarterly Revenue

•

in mil. unless spec.

Quarterly Earnings Per Share

•

in mil. unless spec.

Quarterly Dividends Per Share

•

in mil. unless spec.

Company Description

CEO: Mr. Tianle Ru
Full Time Employees: 4,542
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Address: Baohe industrial park Hefei People's Republic of China
IPO Date: Sep 20, 2000
Website: bbcayy.com
Similar Companies: Dong-A ST Co., Ltd. (170900.KS)
Jiangsu Kanion Pharmaceutical Co.,Ltd. (600557.SS)
Ind-Swift Limited (INDSWFTLTD.BO)
One World Products, Inc. (OWPC)
Nextleaf Solutions Ltd. (OILFF)
Duopharma Biotech Berhad (7148.KL)
Business: Anhui Fengyuan Pharmaceutical Co., Ltd. researches and develops, produces, and sells biological pharmacy, chemical pharmacy, and traditional Chinese medicines primarily in China. It offers antipyretic-analgesic, cardiovascular, antibiotic, nervous system, anti-tumor, antiulcer, and hormone drugs, as well as nutraceuticals. The company also provides general medicines for vitamin and mineral deficiency; medicines for resisting parasitic diseases and microorganisms; coenzymes; and antiviral and uterine contractive medicines. In addition, it offers sedative-hypnotic drugs; drugs for curing mesenteric stress syndrome; drugs for lowering blood pressure; and drugs for curing benign prostatic hyperplasia. The company also exports its products to Europe, North America, Africa, Southeast Asia, and Central Asia. Anhui Fengyuan Pharmaceutical Co., Ltd. was founded in 1997 and is based in Hefei, China.

	Sep'24	Dec'24	Mar'25
ST Debt	653	771	739
LT Borrowings	211	196	273
LT Finance Leases	15	17	15
Preferred Equity and Hybrid Capital	- -	- -	- -
Shares Outstanding	465	465	465
Market Capitalization	2,846	2,850	2,859

	Sep'24	Dec'24	Mar'25
Total Current Assets	2,015	1,965	2,022
Accounts Receivable, Net	1,022	935	1,016
Cash, Cash Equivalents & STI	241	251	228
Inventories	579	593	598
Total Current Liabilities	2,159	2,188	2,168
Payables & Accruals	- -	- -	- -
ST Debt	653	771	739
Deferred Revenue	- -	- -	- -

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	TTM
Revenue per Share	4.55	3.65	3.89	3.59	4.65	5.89	6.79	7.4	7.6	8.36	9.02	9.2	9.22	8.83
Basic EPS, GAAP	0.05	0.07	0.09	0.08	0.1	0.15	0.14	0.18	0.24	0.28	0.35	0.34	0.35	0.33
Free Cash Flow per Basic Share	-0.14	-0.44	-0.38	0.02	0.13	0.01	0.34	-0.18	0.23	0.24	0.81	0.22	-0.04	-0.44
Dividend per Share	0.06	0.12	0.07	0.07	0.14	0.08	0.07	0.12	0.09	0.06	0.13	0.14	0.16	0.16
Book Value per Share	1.21	1.17	1.21	1.25	1.28	1.44	1.55	1.67	1.9	2.19	2.47	2.63	3.13	3.21
Tangible Book Value per Share	1.63	2.24	2.2	2.32	2.29	2.45	2.51	2.62	2.81	3.52	3.38	3.5	3.75	3.84
Basic Weighted Avg Shares	364	419	437	437	437	438	444	438	437	437	444	465	465	465
Sales/Revenue/Turnover	1,658	1,530	1,699	1,569	2,034	2,578	3,013	3,238	3,321	3,652	4,004	4,275	4,285	4,105
Operating Margin (%)	2.24	3.35	3.87	4.1	4.52	5.16	4.61	4.86	4.85	5.52	5.8	5.66	5.76	5.31
Depreciation Expense	52	59	69	64	69	75	75	71	71	115	122	126	128	- -
Net Income, GAAP	19	27	41	35	46	65	61	81	104	123	154	159	161	152
Effective Tax Rate (%)	28.45	33.93	27.09	25.31	31.32	32.41	34.79	32.79	26.08	26.26	25.38	26.8	24.47	20.12
Profit Margin (%)	1.15	1.79	2.41	2.24	2.25	2.53	2.02	2.5	3.12	3.37	3.86	3.73	3.75	3.7
Working Capital	10	266	9	-26	-71	6	-52	-296	-363	-70	-267	-111	-223	-146
LT Debt	60	197	68	59	43	- -	- -	105	65	115	190	195	213	288
Total Equity	775	1,120	1,147	1,199	1,153	1,220	1,292	1,327	1,448	1,771	1,755	1,919	2,046	2,090
Return on Invested Capital (%)	2.52	2.52	2.95	2.81	3.6	5.13	5.27	5.83	5.8	6.49	6.91	6.77	6.55	5.79
Return on Capital (%)	4.5	4.62	6.13	5.36	5.77	7.68	7.41	8.89	9.38	9.95	10.36	9.67	8.49	7.69
Return on Common Equity (%)	4.41	5.89	8.05	6.55	8.31	11	9.25	11.42	13.29	13.77	15.05	13.75	12.02	11

Year	Q1	Q2	Q3	Q4	FY
2023	1,206	1,079	939	1,051	4,275
2024	1,121	1,187	954	1,023	4,285
2025	941	- -	- -	- -	- -

Anhui Fengyuan Pharmaceutical Co., Ltd.

Growth Rates

(avg. rate of change)

Company Description

Growth Rates

(avg. rate of change)

Capital Structure

Working Capital

Quarterly Earnings Per Share

Year

Quarterly Revenue

Year

Quarterly Dividends Per Share

Year